ВЗАИМОСВЯЗЬ ОФВ-1 И ФРАКЦИИ ВЫБРОСА ЛЕВОГО ЖЕЛУДОЧКА ПРИ ХОБЛ В СОЧЕТАНИИ С ХСН РАЗЛИЧНОЙ СТЕПЕНИ ТЯЖЕСТИ
Keywords:
ХОБЛ; ХСН; ОФВ1; фракция выброса левого желудочка; коморбидность; спирометрия; эхокардиография; бронхитический фенотип; кардиопульмональная дисфункция.Abstract
изучить взаимосвязь между объёмом форсированного выдоха за 1 секунду (ОФВ1) и фракцией выброса левого желудочка (ФВЛЖ) при различных степенях тяжести ХОБЛ в коморбидности с ХСН, а также оценить влияние клинического фенотипа ХОБЛ на параметры внешней дыхательной функции и внутрисердечной гемодинамики.
References
Ruvuna L, Sood A. Epidemiology of Chronic Obstructive Pulmonary Disease. Clin Chest Med. 2020;41(3):315–327. doi:10.1016/j.ccm.2020.05.002
GBD 2016 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016. Lancet. 2017;390(10100):1211–1259.
Benjamin EJ, Blaha MJ, Chiuve SE et al. Heart disease and stroke statistics—2017 update: a report from the American Heart Association. Circulation. 2017;135(10):e146–e603.
Rutten FH, Cramer MJ, Grobbee DE et al. Unrecognized heart failure in elderly patients with stable chronic obstructive pulmonary disease. Eur Heart J. 2005;26(18):1887–1894.
Macchia A, Rodriguez Moncalvo JJ, Kleinert M et al. Unrecognised ventricular dysfunction in COPD. Eur Respir J. 2012;39(1):51–58.
Axson EL, Ragutheeswaran K, Sundaram V et al. Hospitalisation and mortality in patients with comorbid COPD and heart failure: a systematic review and meta-analysis. Respir Res. 2020;21(1):54.
McCullough PA, Hollander JE, Nowak RM et al. Uncovering heart failure in patients with a history of pulmonary disease. Acad Emerg Med. 2003;10(3):198–204.
Barr RG, Bluemke DA, Ahmed FS et al. Percent emphysema, airflow obstruction, and impaired left ventricular filling. N Engl J Med. 2010;362(3):217–227.
Hawkins NM, Petrie MC, Jhund PS et al. Heart failure and chronic obstructive pulmonary disease: diagnostic pitfalls and epidemiology. Eur J Heart Fail. 2009;11(2):130–139.
Morgan AD, Zakeri R, Quint JK. Defining the relationship between COPD and CVD: what are the implications for clinical practice? Ther Adv Respir Dis. 2018;12:1753465817750524.
Brightling C, Greening N. Airway inflammation in COPD: progress to precision medicine. Eur Respir J. 2019;54(2):1900455.
Wannamethee SG, Shaper AG, Papacosta O et al. Lung function and airway obstruction: associations with circulating markers of cardiac function and incident heart failure in older men. Thorax. 2016;71(6):526–534.
Freixa X, Portillo K, Paré C et al. Echocardiographic abnormalities in patients with COPD at their first hospital admission. Eur Respir J. 2013;41(4):784–791.
McDonagh TA, Metra M, Adamo M et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021;42(36):3599–3726.
Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, management and prevention of COPD. 2020 Report. goldcopd.org.





